During the past decade, General Hospital Varazdin conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 14 clinical trials were completed, i.e. on average, 155.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Varazdin" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Puma Biotechnology, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Varazdin" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Varazdin" are "Breast Cancer" (5 trials), "Multiple Sclerosis" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Acute Appendicitis" (1 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "General Hospital Varazdin" in a lesser frequency.

Most popular intervention types in "General Hospital Varazdin" are "Drug" (19 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Interferon beta-1a" (3 trials), "Ocrelizumab" (3 trials), "Carboplatin" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Varazdin" are 22 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "General Hospital Varazdin". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in General Hospital Varazdin, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Varazdin, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

General Hospital Varazdin has several departments that took part in Clinical trials: "Opća bolnica Varaždin, Klinika za Neurologiju" - 2 trials